13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
117 檔
30.3%
Eversept Partners, LP 在 Q1 2026 季度的美股仓位总计估值为 US$19.3亿，分散于 117 个持仓标的之中，反映其市场参与广度与投资规模。
Eversept Partners, LP 在 Q1 2026 进行了结构性的板块轮动与仓位换股。在开立 40 个全新仓位及加仓 37 档持股的同时，亦同步清仓 30 档并减仓 37 档标的。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 UTHR, QQQ, ABVX 等）合计占整体申报市值的 30.3%，反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
QGEN
市值: US$4090.6万
本季最大获利了结 / 清仓标的
DHR
前期市值: US$4263.9万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 8.26% | -0.17% | +4.62% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 7.26% | -3.49% | +6.09% | |
| 3 | ABVX | Abivax Sa-adr | 股票-其他 | 5.49% | +0.83% | +42.05% | |
| 4 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 5.20% | -3.89% | -33.38% | |
| 5 | VERA | Vera Therapeutics Inc | 股票-其他 | 4.61% | +0.32% | -29.26% | |
| 6 | NTRA | Natera Inc | 股票-医疗保健 | 4.06% | -1.58% | +15.01% | |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 3.67% | -3.67% | EXIT | |
| 8 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 3.55% | -0.38% | -12.94% | |
| 9 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 2.99% | +0.46% | +24.62% | |
| 10 | PCVX | Vaxcyte Inc | 股票-其他 | 2.83% | -0.93% | -22.84% | |
| 11 | BKD | Brookdale Senior Living Inc | 股票-其他 | 2.57% | +0.27% | +851.79% | |
| 12 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 2.50% | +0.23% | +17.44% | |
| 13 | QGEN | Qiagen N.V. | 股票-医疗保健 | 2.16% | -2.02% | — | |
| 14 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 2.12% | -2.12% | EXIT | |
| 15 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.98% | +0.01% | -17.36% | |
| 16 | TLT | Ishares 20+ Year Treasury Bd | ETF-政府公债 | 1.96% | -1.96% | EXIT | |
| 17 | WELL | Welltower Inc | 股票-房地产 | 1.89% | -0.86% | — | |
| 18 | DOC | Healthpeak Properties Inc | 股票-房地产 | 1.72% | -1.72% | EXIT | |
| 19 | PODD | Insulet CORP | 股票-医疗保健 | 1.59% | -0.41% | +92.14% | |
| 20 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 1.53% | -0.56% | +1.57% | |
| 21 | GERN | Geron CORP | 股票-其他 | 1.48% | -0.24% | +6.65% | |
| 22 | OHI | Omega Healthcare Investors | 股票-房地产 | 1.35% | -0.15% | — | |
| 23 | LQDA | Liquidia CORP | 股票-其他 | 1.35% | +0.42% | +32.97% | |
| 24 | CYH | Community Health Systems Inc | 股票-其他 | 1.35% | +0.01% | +9.23% | |
| 25 | AVTR | Avantor Inc | 股票-医疗保健 | 1.23% | -1.23% | EXIT | |
| 26 | EHC | Encompass Health CORP | 股票-医疗保健 | 0.99% | +4.39% | +81.53% | |
| 27 | LLY | Eli Lilly & Co | 股票-医疗保健 | 0.92% | +0.33% | +78.86% | |
| 28 | TVTX | Travere Therapeutics Inc | 股票-其他 | 0.85% | +1.50% | -53.82% | |
| 29 | INSM | Insmed Inc | 股票-医疗保健 | 0.81% | +0.55% | — | |
| 30 | CTMX | Cytomx Therapeutics Inc | 股票-其他 | 0.79% | -0.10% | +27.18% | |
| 31 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-非投资级债 | 0.76% | -0.76% | EXIT | |
| 32 | RGEN | Repligen CORP | 股票-医疗保健 | 0.75% | -0.65% | — | |
| 33 | BBNX | Beta Bionics Inc | 股票-其他 | 0.75% | +0.27% | +108.60% | |
| 34 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 0.74% | +0.05% | -59.98% | |
| 35 | ARQT | Arcutis Biotherapeutics Inc | 股票-其他 | 0.72% | -0.54% | +32.66% | |
| 36 | ARDX | Ardelyx Inc | 股票-其他 | 0.70% | -0.26% | +29.99% | |
| 37 | LTC | Ltc Properties Inc | 股票-其他 | 0.63% | +0.21% | — | |
| 38 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 0.62% | +0.12% | +121.62% | |
| 39 | CHE | Chemed CORP | 股票-医疗保健 | 0.62% | +0.65% | — | |
| 40 | PHVS | Pharvaris N.V. | 股票-其他 | 0.61% | +0.08% | -7.34% | |
| 41 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 0.57% | +0.53% | -34.28% | |
| 42 | IWM | Ishares Russell 2000 ETF | ETF-中小型股 | 0.52% | -0.52% | EXIT | |
| 43 | PNTG | Pennant Group Inc/the | 股票-其他 | 0.50% | +0.38% | +6.20% | |
| 44 | XLK | Ss Technology Select Sector | ETF-科技型 | 0.49% | -0.49% | EXIT | |
| 45 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.48% | — | -32.09% | |
| 46 | PALI | Palisade Bio Inc | 股票-其他 | 0.46% | -0.01% | -7.49% | |
| 47 | MRNA | Moderna Inc | 股票-医疗保健 | 0.43% | +0.12% | -40.37% | |
| 48 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 0.41% | +0.81% | — | |
| 49 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.40% | -0.40% | EXIT | |
| 50 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 0.40% | +0.22% | -44.00% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | BKD | Brookdale Senior Living Inc | +2.4% | +851.79% | 加仓 |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | +2.1% | +138.31% | 加仓 |
| 3 | UTHR | United Therapeutics CORP | +2.1% | +4.62% | 加仓 |
| 4 | CLDX | Celldex Therapeutics Inc | +1% | +24.62% | 加仓 |
| 5 | ABVX | Abivax Sa-adr | +1% | +42.05% | 加仓 |
| 6 | TLT | Ishares 20+ Year Treasury Bd | +1% | +86.43% | 加仓 |
| 7 | PODD | Insulet CORP | +0.5% | +92.14% | 加仓 |
| 8 | LQDA | Liquidia CORP | +0.5% | +32.97% | 加仓 |
| 9 | EHC | Encompass Health CORP | +0.4% | +81.53% | 加仓 |
| 10 | BCRX | Biocryst Pharmaceuticals Inc | +0.4% | +1.57% | 加仓 |
| 11 | IONS | Ionis Pharmaceuticals Inc | +0.4% | +17.44% | 加仓 |
| 12 | BMRN | Biomarin Pharmaceutical Inc | +0.3% | +121.62% | 加仓 |
| 13 | LLY | Eli Lilly & Co | +0.3% | +78.86% | 加仓 |
| 14 | GERN | Geron CORP | +0.3% | +6.65% | 加仓 |
| 15 | QQQ | Invesco Qqq Trust Series 1 | +0.3% | +6.09% | 加仓 |
| 16 | CTMX | Cytomx Therapeutics Inc | +0.3% | +27.18% | 加仓 |
| 17 | ARDX | Ardelyx Inc | +0.2% | +29.99% | 加仓 |
| 18 | NTRA | Natera Inc | +0.2% | +15.01% | 加仓 |
| 19 | CYH | Community Health Systems Inc | +0.1% | +9.23% | 加仓 |
| 20 | PNTG | Pennant Group Inc/the | +0.1% | +6.20% | 加仓 |
| 21 | ARQT | Arcutis Biotherapeutics Inc | +0.1% | +32.66% | 加仓 |
| 22 | ALEC | Alector Inc | +0.1% | +34.28% | 加仓 |
| 23 | EHABUSD | Enhabit Inc | +0.1% | +4.09% | 加仓 |
| 24 | SVRA | Savara Inc | +0.1% | +125.78% | 加仓 |
| 25 | PCVX | Vaxcyte Inc | +0.1% | -22.84% | 减仓 |
| 26 | SNDX | Syndax Pharmaceuticals Inc | 0% | -12.94% | 减仓 |
| 27 | WHWK | Whitehawk Therapeutics Inc | 0% | +17.88% | 加仓 |
| 28 | MRNA | Moderna Inc | 0% | -40.37% | 减仓 |
| 29 | CTNM | Contineum Therapeutics Inc-a | 0% | +6.49% | 加仓 |
| 30 | SSII | Ss Innovations International | 0% | +46.18% | 加仓 |
| 31 | EDIT | Editas Medicine Inc | 0% | — | 不变 |
| 32 | PLRX | Pliant Therapeutics Inc | 0% | +5.87% | 加仓 |
| 33 | PHVS | Pharvaris N.V. | — | -7.34% | 减仓 |
| 34 | NVCR | NovoCure Limited | — | +11.52% | 加仓 |
| 35 | RVP | Retractable Technologies Inc | — | — | 不变 |
| 36 | INMD | InMode Ltd. | — | +9.37% | 加仓 |
| 37 | STRO | Sutro Biopharma Inc | 0% | -62.20% | 减仓 |
| 38 | BCYC | Bicycle Therapeutics Plc-adr | 0% | +6.60% | 加仓 |
| 39 | AVR | Anteris Technologies Global | 0% | -19.76% | 减仓 |
| 40 | AMRN | Amarin CORP PLC -adr | 0% | -14.21% | 减仓 |
| 41 | IFRX | InflaRx N.V. | 0% | +0.07% | 加仓 |
| 42 | SRZN | Surrozen Inc | 0% | -38.48% | 减仓 |
| 43 | SLQT | Selectquote Inc | 0% | — | 不变 |
| 44 | EHTH | Ehealth Inc | 0% | -0.74% | 减仓 |
| 45 | ✓ | Engene Holdings Inc | 0% | +12.00% | 加仓 |
| 46 | PASG | Passage Bio Inc | 0% | +4.24% | 加仓 |
| 47 | RLAY | Relay Therapeutics Inc | -0.1% | -44.66% | 减仓 |
| 48 | SPRY | Ars Pharmaceuticals Inc | -0.1% | -45.85% | 减仓 |
| 49 | GPCR | Structure Therapeutics Inc | -0.1% | +8.21% | 加仓 |
| 50 | BVS | Bioventus Inc - A | -0.1% | -66.24% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q1 2026 季度的美股持仓总市值约为 US$19.3亿，共申报了 117 个公开持股仓位。
在 Q1 2026 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：UTHR (8.3%)、QQQ (7.3%)、ABVX (5.5%)。其中最大持股仓位 UTHR 占据整体投资组合约 8.3% 的权重。
在 Q1 2026 季度中，Eversept Partners, LP 共进行了 144 项持仓异动，包含新建仓 40 个仓位、加仓 37 个仓位、减仓 37 个仓位以及清仓 30 个仓位。 其中最大新建仓标的为 QGEN。 本季清仓仓位包含 DHR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。